Silexion Therapeutics Corp (SLXN) stock
Close on Nov 18, 2026Market cap $868.40KP/E –Yield –
Earnings
Silexion Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Silexion Therapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 11, 2026Expected | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 14, 2026before the open | – | – | -$5.17 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 18, 2026before the open | – | – | $0.85 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025before the open | – | – | -$2.88 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 12, 2025before the open | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 13, 2025after the close | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 18, 2025after the close | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 14, 2024before the open | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Silexion Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Silexion Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Silexion Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Update
- Update
- Results
- News
- News
- News
- Update
- Update
- Update
- News
- News
- News
- Results
See a number that looks wrong?